Virax Biolabs Group Limited

VRAX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.50

+$0.19 (+8.23%)

At close: Sep 22, 2026, 4:00 PM ET

$2.50

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+8.23%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $466.56K

1D Range

2.28 2.65

52W Range

2.15 21.75

Valuation (TTM)

PE -0.14

PB 0.06

EV/EBITDA 0.94

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $1

Cash Flow

FCF Yield -1169.3%

SBC Adj. FCF Yield -1187.6%

SBC Impact -1.6%

Margins

Gross Margin -1480.5%

Operating Margin -51515.2%

FCF Margin -40576.6%

Growth (CAGR)

Revenue 3Y | 5Y -50.1% | -36.9%

Dil EPS 3Y | 5Y 22.9% | 20.8%

FCF 3Y | 5Y -47.9% | -19.8%

Returns

ROA -88.4%

ROE -114.2%

ROIC -100.0%

Financial Health

Net Cash

$6.49M

Current Ratio 9.97

Interest Coverage -96.86

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intende...

Sector Healthcare

Industry Biotechnology

Employees 26

IPO Date Jul 20, 2022

Website viraxbiolabs.com

Fiscal Year April - March

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Downside

-60.00%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞